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Abstract: The construction and electrochemical response characteristics of a poly(vinyl 
chloride) (PVC) membrane selective electrode for the determination of sulpiride (SPD) are 
described. The sensing membrane comprised an ion-exchanger formed between the 
protonated drug and tetraphenylborate (TPB
-) in a plasticized PVC matrix. The influence 
of membrane composition on the electrode response was studied. The electrode showed a 
fast, stable and Nernstian response over a sulpiride concentration range (1  ×  10
-4  –  
1 × 10
-2 M) with a mean slope of 58.4 ± 0.9 mV dec
-1 of concentration, a mean detection 
limit of 4.2 × 10
-5 ± 1.2 × 10
-5 M, a wide working pH range (2 – 8) and a fast response time 
(< 15 s). The electrode showed good selectivity towards sulpiride with respect to some 
inorganic and organic compounds. When the electrode was applied to the determination of 
sulpiride in pharmaceuticals and human urine, a high percentage of recovery was attained 
with no need for sample pretreatment procedures because of the lack of interfering matrix 
effects. 
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1. Introduction  
 
Substituted benzamides are atypical neuroleptics and highly selective for dopamine receptors. The 
main pharmacological characteristics of these drugs include their ability to bind to a subgroup of 
dopamine D2 receptors, which may be located on the presynaptic terminal. Substituted benzamides 
were the first class of atypical anti-psychotics to be successfully used for schizophrenia and   
depression [1]. 
Sulpiride (SPD) 5-(aminosulfonyl)-N-[(1-ethylpyrrolidin-2-yl)methyl]-2-methoxybenzamide, a 
substituted benzamide with antipsychotic properties, acts as antagonist of the dopamine D2 receptors, a 
property which distinguishes from other antipsychotic agents. This particular feature may explain the 
very low incidence of side effects on the extrapyramidal system. It is used for treatment of 
psychopathological disorders, including neurosis, depression, schizophrenia, the psychopathology of 
senescence, anorexia, gastric or duodenal ulcers and irritable colon due to psychosomatic stress and 
various vertigo syndromes [2]. 
Figure 1. Sulpiride. 
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Typical pharmaceuticals which contain sulpiride include Dogmatil, Dolmatil, Sulpor and Guastil, in 
different forms, e.g. tablets, capsules, injectable ampoules, and suspensions containing 50 – 200 mg of 
sulpiride per unit.  
Sulpiride is efficiently absorbed after oral administration and is eliminated principally by hepatic 
metabolism and subsequent urinary excretion. The normal dose of adults is 150 – 300 mg day
-1 and for 
children 25 – 200 mg day
-1. Its oral bioavailability is only 25 to 35%, with marked inter-individual 
differences. The peak plasma concentration is reached 4.5 hours after oral dosing. The usual half-life is 
6 to 8 hours. Sulpiride is usually given in 2 or 3 divided doses and undergoes only limited metabolism: 
nearly 70 – 90 % of an intravenous injection and 15 – 20 % of an orally administered dose is excreted 
unchanged in urine [3]. Typical biological fluids examined for sulpiride concentrations are human 
serum and urine. Concentrations of sulpiride in the fluids of treated patients are in the ranges 0.03 – 
0.6 and 10 – 360 μg mL
-1, respectively 
A review of the literature revealed that several analytical methods have been described for the 
determination of sulpiride in pharmaceuticals or biological fluids, including spectrophotometric [4-7], 
fluorimetric [8], chromatographic [9-14], electrophoretic [15-17], voltammetric [18] and chemi-
luminometric [19]; however, the methods proposed for the analysis of biological fluids suffer the 
inconvenience of time-consuming procedures and expensive instrumentation. 
In recent decades potentiometric membrane ion-selective electrodes (ISEs) have been used in 
pharmaceutical and biological analyses [20-29] because these sensors offer the advantage of simple 
design and operation, low cost, fast response, low detection limit, adequate selectivity, good accuracy, Sensors 2009, 9                  
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wide concentration range, applicability to coloured and turbid solutions and possible interfacing with 
automated and computerized systems. However, a thorough literature survey has revealed no methods 
that use selective electrodes for the determination of sulpiride. 
Tetraphenylborate derivatives have been used extensively in the composition of ion-selective 
electrode membranes. Although they can not form specific strong ion pairs they seem to play an active 
role as complexing agents [30,31]. Thus, the selectivity of some organic cations-selective electrodes 
based on tetraphenylborate derivates as charge carriers is significantly influenced by the charged 
carrier used.  
The aim of this work was to develop a polymeric ion-selective electrode for sulpiride determination 
in pharmaceuticals, and human urine. The overall aim is to develop sensors for point-of-care clinical 
analysis in the treatment of mentally ill patients. 
 
2. Experimental Section 
 
2.1. Reagents and solutions 
 
Poly(vinyl chloride) (PVC); 2-nitrophenyl octyl ether (NPOE); bis(2-ethylhexyl) sebacate (DOS); 
dibutylphtalate (DBP); tetrahydrofuran (THF); (±) sulpiride powder and sodium tetraphenylborate 
(NaTPB). Nanopure water (Resistivity in MΩ·cm at 25 °C = 18.2) prepared with a Milli-Q (Millipore) 
system was used throughout.  
Standard sulpiride hydrochloride solution 5 x 10
-2 M, prepared by dissolving 1.707 g of pure drug 
in 0.5 mL of conc. HCl and diluting with water to 100 mL. Working solutions (1 × 10
-6 to
 2 × 10
-2 M)
 
were prepared by appropriate serial dilutions with acetic/acetate buffer solution of pH 4.7 and   
2 × 10
-1 M concentration.  
Sodium tetraphenylborate 1 × 10
-2M, prepared by dissolving 0.3422 g of sodium tetraphenylborate 
to 100 mL with water. 
Dosage form of sulpiride: Dogmatil 50 capsules (Sanofil-Synthelbe SA, Spain), contained 50 mg 
sulpiride, lactose, methylcellulose, talc, magnesium stearate and other excipients to total capsule 
weight; Dogmatil solution (Sanofil-Synthelbe SA, Spain): 500 mg sulpiride, sodium cyclamate, 
hydroxyethylcellulose, methylparaben, propylparaben, citric, hydrochloric and sorbic acids, lemon 
essence and water to 100 mL. Guastil pedriatic suspension (Uriach, Spain): 500 mg sulpiride, 
sacharose, sodium saccharin, microcrystalline cellulose, sodium carmelose, sodium chloride, methyl p-
hydroxybenzoate, propyl p-hydroxybenzoate, strawberry essence and water to 100 mL. 
 
2.2. Ion-exchanger preparation 
 
The sulpiride tetraphenylborate (SPD-TPB) ion exchanger was prepared by reacting 25 mL of   
2 × 10
-2 M sulpiride hydrochloride solution with 50 mL 1 × 10
-2 M sodium tetraphenylborate solution. 
The mixture was filtered through a porous number 4 sintered glass crucibles. The residue was first 
washed with distilled water until no chloride ion was detected in the washing solution and then with 
hexane before being dried at room temperature.  Sensors 2009, 9                  
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2.3. Construction and conditioning of the electrode 
 
The membranes were prepared by dissolving 3.0 or 9.0 mg of SPD-TPB, 100 mg PVC and 200 mg 
of the plasticizer (NPOE, DOS or DBP) in 3 mL of tetrahydrofuran. This solution was poured into a 
Fluka glass ring (inner diameter 28 mm, height 30 mm) on a Fluka glass plate, and allowed to 
evaporate overnight. A 7 mm diameter piece was cut out with a Fluka punch for ion-selective 
membranes and incorporated into a Fluka electrode body ISE containing 1 × 10
-2 M potassium 
chloride and 1 × 10
-3 M sulpiride, and saturated with excess AgCl as internal filling solution. The 
composition of the different membranes assayed is shown in Table l. 
Table 1. Composition of the membranes. 
Percentage (w/w) of components in membranes  
Membrane PVC  NPOE  DBP  DOS  SPD-TFB 
A 33.0  66.0  ----  ---- 1.0 
B 33.0  ----  66.0 ---- 1.0 
C 33.0  ----  ---- 66.0  1.0 
D 32.3  64.7  ----  ---- 3.0 
 
The electrodes were conditioned by soaking with constant stirring in a solution containing   
1 × 10
-3 M sulpiride in acetate/acetic buffer of pH 4.7 until the electrode provided a constant potential. 
When not in use, the electrode was kept immersed in the same solution. 
 
2.4. Measurement system 
 
Potentials were measured with an Orion 960 Autochemistry System, the recorder output of which 
was connected to a personal computer, with acquisition program, via a DGH Corporation 1121 module 
analogue-to-digital converter (Manchester, UK). An Orion 90-02 double junction silver-silver chloride 
reference electrode containing 10 % (w/w) solution of KNO3 in the outer compartment and a Fluka 
electrode body ISE, were used. Figure 2 shows the measurement system used.  
Figure 2. Measurement system used. A: Sulpiride selective electrode; B: Stirrer; C: 
Reference electrode; D: Sample; E: Potentiometer; F: Analogue-to-digital converter; G: 
Personal computer. 
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2.5. General procedure (calibration of the electrode) 
 
Standard sulpiride solutions of 1 × 10
-6 – 2 × 10
-2 M in acetate/acetic buffer of pH 4.7 were 
prepared. The sulpiride-selective and reference electrodes were immersed and the potential of each 
sample solution was directly measured. The measured potentials were then plotted versus logarithmic 
values of concentrations and the calibration parameters were calculated by fitting calibration data to 
the equation shown in section 3.3. For the dynamic response studies, the electrode was calibrated by 
injecting, while stirring, adequate small volumes of sulpiride standard solution in 50 mL of 
acetate/acetic buffer of pH 4.7 to obtain final concentrations in the range 1 × 10
-6 – 1 × 10
-2 M.  
 
2.6. Procedure for the determination of sulpiride in dosage form 
 
The content of sulpiride in capsules was determined by analysing five capsules separately. The 
powder content in each capsule was shaken with 0.5 mL conc. HCl and 5 mL of water. The mixture 
was then introduced into an ultrasonic bath for 5 min and diluted with water in a calibrated 10 mL 
flask. An accurately measured volume (100 μL - 2 mL) of this solution was diluted with acetic/acetate 
buffer of pH 4.7 in a calibrated 25 mL flask. For pharmaceuticals in solution or suspension, an 
accurately measured volume (100 μL – 2 mL) of this solution was directly taken and diluted to 25 mL 
with acetic/acetate buffer of pH 4.7. The potential of the different solutions was measured using the 
procedure described in section 2.5 and the SPD concentration was obtained by referring to a 
calibration plot obtained under identical experimental conditions for standard solutions of SPD. To 
validate the proposed method 500 μL aliquots of pharmaceutical solution samples, equivalent to   
2.5 mg of SPD, to which different volumes (500 – 1,500 μL) of SPD 5 × 10
-2 M solution were added, 
were diluted to 25 mL with acetic/acetate buffer of pH 4.7 and analyzed in triplicate by the 
potentiometric procedure described above. 
 
2.7. Procedure for the determination of sulpiride in human urine 
 
Urine samples containing different sulpiride concentrations were prepared by adding known 
amounts of sulpiride to 25 mL aliquots of blank urine samples of four volunteers, the sulpiride-
selective and reference electrodes were immersed and the sulpiride concentration was determined by 
direct potentiometry using the standard additions technique. 
 
3. Results and Discussion 
 
3.1. Influence of membrane composition 
 
Four membranes of the different compositions (Table 1), prepared as described in the Experimental, 
were tested. Three plasticizers, with very different dielectric constants, were tested as membrane 
solvent, NPOE (ε = 23.9), DBP (ε = 6.4) and DOS (ε = 4). The calibration graphs obtained for the 
corresponding membranes, A, B and C, respectively, are shown in Figure 3.  Sensors 2009, 9                  
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Figure 3. Calibration graphs of sulpiride obtained with the membranes A, B, C, D. 
 
 
As can be seen, the membrane plasticized with NPOE showed a better response and also presented 
a lower detection limit than the other two membranes, 3.7 × 10
-5 M, 1.7 × 10
-4 M and 4.1 × 10
-3 M, 
respectively. As it is known, the detection limit of ISEs with dissolved ion exchangers is controlled by 
the analyte ion concentration present in the solution as a result of the distribution equilibrium of the 
ion pair between the membrane and the solution [32]. The solubility of the ion-pair in the organic 
solvent generally increases as the polarity and dielectric constant increases [33], which explain the 
lower detection limit obtained with NPOE as plasticizer. The NPOE was selected for further studies. 
Two different ion exchanger SPD-TPB concentrations in the membrane were tested, 1.0 and 3.0 % 
(membranes A and D, respectively). The corresponding calibration graphs, Figure 3, show similar 
responses with both ion-pair concentrations, but the detection limit of membrane A (3.7 × 10
-5 M) was 
lower than that of membrane D (1 × 10
-4 M), due to the lower SPD concentration in the aqueous 
solution as a result of the distribution equilibrium of the ion-exchanger. Accordingly, the membrane A 
was selected for further studies. 
 
3.2. Influence of pH 
 
The effect of pH on the electrode potential at various sulpiride concentration in the range 1 × 10
-5 – 
1 × 10
-2 M was studied. The pH was varied by adding HCl or NaOH, and the results obtained are 
shown in Figure 4. As can be seen, the electrode potential was little influenced by pH in the range 2-8 
for sulpiride concentrations between 10
-2 – 10
-4 M. At higher pH values, the potential decreased due to 
the gradual increase in the concentration of the deprotonated form of the SPD (pK1 = 8.9). In working 
with ion-selective electrodes for cationic drugs, we have observed some problems of precipitation of at 
high concentrations of the drug and higher pH values. A pH of 4.7 adjusted with 2 × 10
-1 M 
acetic/acetate buffer was used for further studies. Sensors 2009, 9                  
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Figure 4. Influence of pH on the electrode potential for different sulpiride concentrations 
 
 
3.3. Response characteristics 
 
Ion-selective electrode characterization with a mathematical and computational program has been 
shown to be very useful for determining detection limits and selectivity constants [34]. Non-linear 
curve fitting using commonly available software was used for determination of the ISE characteristics 
[35]. The slope (S) and the detection limit (LOD) of the selected electrode were determined by fitting 
calibration data to equation: 
) log(
0
SPD i c LOD S E E     
The calibration parameters, evaluated from repeatedly making calibration graphs for sulpiride   
1× 10
-6 – 1 × 10
-2 M, are shown in Table 2. As can be seen, a near-Nernstian response within a two 
decade concentration range, with low detection limit and good calibration reproducibility, was 
obtained. 
Table 2. Response characteristics of the sulpiride-selective electrode. 
Slope (mV per dec)  S.D.  57.5  0.7 
Linear range (M)  5 × 10
-5 to 1 × 10
-2 
Detection limit (M)  S.D.  3.7 × 10
-5 7.0 × 10
-6 
Response time (s) 10
-6– 10
-2 (M)  t95%15 
Working pH range (10
-6– 10
-2 M)  2 – 8 
Lifetime (day)  ≥ 15 
 
3.4. Reproducibility 
 
The repeatability of the calibration parameters was studied by making four successive calibrations 
with three different membranes 1, 2 and 3, cut out from the same original membrane, on the same day 
(n = 5).  Sensors 2009, 9                  
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Table 3. Repeatability and reproducibility of sulpiride electrode. 
 Repeatibility 
Membrane  S ± SD*  LOD ± SD* 
1  59.4 ± 0.3  5 × 10
-5 ± 2 × 10
-5
2  58.3 ± 0.8  4.9 × 10
-5 ± 0.3 × 10
-5
3  57.6 ± 0.4  2.8 × 10
-5 ± 0.5 × 10
-5
  Reproducibility between days 
1  58 ± 2  4 × 10
-5 ± 2 × 10
-5
2  57 ± 3  4 × 10
-5 ± 2 × 10
-5
3  57 ± 1  1.8 × 10
-5 ± 0.2 × 10
-5
  Reproducibility between membranes 
1,2,3  58.4 ± 0.9  4 × 10
-5 ± 1 × 10
-5
* Mean ± SD (n = 5) 
 
The reproducibility on different days (n = 8) was studied with the three membranes and the 
reproducibility between the three membranes was obtained from the corresponding repeatability 
means. Table 3 shows the good results obtained in all the cases. 
 
3.5. Response time 
 
The dynamic response time is an important factor with selective electrodes. For the proposed ISE, 
the response time was obtained from the dynamic potential response corresponding to sulpiride 
concentration steps between 1 × 10
-6 – 1 × 10
-2 M (shown in Figure 5) by measuring the time required 
to reach 95 % equilibrium potential after increasing the concentration of the drug. The values obtained 
for different sulpiride concentrations are included in Table 2. The response time varied from 4 s for 
higher SPD concentrations and 15 s for lower concentrations. 
Figure 5. Dynamic response of electrode to different sulpiride concentrations. 0:0;   
1:1 × 10
-6 M; 2: 6 × 10
-6 M; 3:1.6 × 10
-5 M; 4: 6.6 × 10
-5 M; 5: 1.6 × 10
-4 M; 6:   
1.1 × 10
-3 M; 7: 9.1 × 10
-3 M. 
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The electrode lifetime was obtained by periodically performing calibration graphs for SPD and 
calculating the response slopes. The sulpiride selective electrode worked for at least 15 – 20 days, 
during which time no appreciable change in the calibration characteristics or response time was 
observed, while at higher times the slopes of the electrode started to decrease. 
 
3.6. Selectivity 
 
The selectivity of an ion-pair based membrane electrode depends on the physico-chemical 
characteristics of the ion-exchange process at the membrane-sample solution interface, on the mobility 
of the respective ions in the membrane and on the hydrophobic interactions between the ions and the 
organic membrane [36]. The selectivity of the SPD membrane electrode is related to the free energy of 
transfer of the SPD cation between aqueous and organic phases.  
The response of the electrode was studied toward several different substances: inorganic ions, 
organic species frequently present in pharmaceuticals and biological fluids, and other drugs used in 
pharmacological treatments (K
+, NH4
+, Ca
2+, Mg
2+, glucose, lactose, saccharose, urea, uric acid, 
hipuric acid, amoxicillin, cimetidine, ofloxacine, diclofenac, carbamazepine and ranitidine). Figure 6 
shows the calibration graphs corresponding to the different species assayed. As can be seen, the 
electrode did not respond to Ca
2+, Mg
2+, glucose, lactose, sucrose, urea, uric acid, hipuric acid, 
amoxiciline, diclofenac or carbamazepine at concentrations lower than 2 × 10
-1 M and to K
+, NH4
+ at 
concentrations lower than 1 × 10
-2 M. The electrode gave a near Nernstian response to ranitidine, 
ofloxacine and cimetidine.  
Figure 6. Calibration graph for sulpiride and interferent ions. Curves: 1 ranitidine; 2 
sulpiride; 3 ofloxacine; 4 cimetidine; 5 K
+; 6 NH4
+; 7 – 17 Ca
2+, Mg
2+, glucose, lactose, 
sucrose, urea, uric acid, hipuric acid, amoxiciline, diclofenac and carbamazepine 
respectively. 
 
 
The selectivity coefficients of these three species were determined by applying the separate solution 
method comparing the concentrations that generate the same potential of the primary and interfering Sensors 2009, 9                  
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ion. The concentration of SPD that corresponds to the same potential observed for ranitidine, 
ofloxacine and cimetidine 1 × 10
-2 M was calculated using its calibration graph and the selectivity 
coefficients were calculated with equation : KSPD, J = CSPD/CJ. The values obtained were 1.4; 0.9 and 
0.06 respectively. 
The selectivity coefficient for sodium was determined because this ion is present in high 
concentrations in urine. The value calculated from the potential measured in a 2 M NaCl solution was 
10
-5.2. Therefore, and taking into account the sodium and sulpiride concentration levels present in 
urine, no interference from sodium in the determination of sulpiride in urine is expected. 
 
3.7. Analytical applications 
 
The new sulpiride-selective electrode was satisfactorily applied to the determination of the drug in 
pharmaceuticals and human urine. 
In the case of pharmaceuticals, the possible interference of different excipients and additives used 
frequently in pharmaceutical containing sulpiride was studied by adding different amounts of the 
possible interferent to samples containing 10
-3  M SPD and applying the proposed method. No 
interference was observed in the presence of cellulose, saccharose, sorbic acid, sodium saccharine, 
magnesium stearate or talc, even at amounts higher than these contained in pharmaceuticals. 
Table 4 shows the results obtained applying the proposed method to the dosage forms analyzed. 
The results obtained were in good agreement with the certified values. 
Table 4. Determination of sulpiride in pharmaceuticals. 
 Sulpiride 
Sample Labeled  Found
(*) % Recovery 
(*) 
Dogmatil capsules  50 
(a) 50.10 ± 0.28 
(a) 100.2 ± 0.6 
Dogmatil solution  50 
(b) 50.11 ± 0.24 
(b) 100.2 ± 0.5 
Guastil suspension  50 
(b) 49.98 ± 0.58 
(b) 99.9 ± 1.2 
(*) Mean ± SD (n = 5); 
(a) SPD mg /capsule; 
(b) SPD mg /10 mL. 
Table 5. Determination of sulpiride in pharmaceuticals. 
 Sulpiride 
Sample Labeled Added  Found  %  Recovery 
(*) 
Dogmatil   50 
(a)  8.54
(a) 8.58 ± 0.02 100.5 ± 0.2 
capsules   17.08
(a)   17.18 ± 0.02   100.6 ± 0.1 
   25.62
(a) 25.49 ± 0.05 99.5 ± 0.2 
Dogmatil   50
 (a)  8.54
(b) 8.56 ± 0.06  100.3 ± 0.7 
solution  17.08
(b) 17.18 ± 0.04 100.6 ± 0.2 
   25.62
(b) 25.57 ± 0.01  99.8 ± 0.1 
Guastil   50
 (b)  8.54
(b) 8.61 ± 0.02  100.8 ± 0.3 
solution  17.08
(b) 16.92 ± 0.18 99.1 ± 1.1 
   25.62
(b) 25.59 ± 0.10  99.9 ± 0.4 
(*) Mean ± SD (n = 5); 
(a) SPD mg /capsule; 
(b) SPD mg /10 mL. Sensors 2009, 9                  
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The validity of the proposed method was confirmed by applying the standard addition technique to 
the pharmaceuticals analyzed. The results obtained are shown in Table 5. In all cases quantitative 
recoveries of between 99.1-100.8 % were obtained. 
For the determination of SPD in human urine, possible interference from the sample matrix was 
previously studied. Four urine samples from different volunteers (urine blanks) were collected and the 
calibration graph for each was obtained by adding appropriate volumes of SPD 5 × 10
-2 M to obtain a 
concentration of SPD between 2 × 10
-5 – 7 × 10
-3 M and applying the procedure described in 2.7. No 
significant differences between the slopes and the detection limits corresponding to these calibrations 
were found and so the sulpiride concentration in urine samples was determined as described in 
Experimental without any pre-treatment procedure of the samples. In the absence of urine samples 
containing SPD, known amounts of SPD were added to blank urine samples and the results obtained 
are summarized in Table 6. 
Table 6. Determination of sulpiride in urine. 
Sulpiride 
Urine Content 
(a) Found 
(a) % Recovery 
1 23.86  23.41  98.1 
 57.69  56.70  98.3 
 125.3  124.7  99.5 
2 23.86  23.25  97.5 
 57.69  57.53  99.7 
 125.3  126.2  100.7 
3 23.86  24.17  101.3 
 57.69  60.87  105.4 
 125.3  124.7  105.4 
4 23.86  24.82  104.0 
 57.69  56.98  98.8 
 125.3  126.3  100.8 
(a) mg/L of urine. 
 
Good recoveries in all urine samples were obtained. The results obtained for different urines 
samples assayed were also compared by applying the t-test at the 95% confidence level. The calculated 
t value (0.52) did not exceed the theoretical value (2.20), indicating that there are no significant 
differences between the content of sulpiride added and it obtained by the proposed method. 
Taking into account the normal dose and the pharmacokinetic of sulpiride mentioned in the 
Introduction, the concentration of SPD in urine passed over a 24 h period is within the range of SPD 
determination of the potentiometric method proposed. 
 
4. Conclusions  
 
The new ion selective electrode developed, based on a plasticized poly (vinyl chloride) (PVC) 
membrane containing the ion-exchanger formed between protonated sulpiride and tetraphenylborate, 
provides a rapid, sensitive, precise and inexpensive method for the direct potentiometric determination Sensors 2009, 9                  
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of sulpiride in pharmaceuticals and in human urine samples, in the physiological concentration range 
obtained after the usual therapeutic dose of sulpiride has been administered. 
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